P 1

Drug Profile

P 1

Alternative Names: PSE 222; Zemaphyte

Latest Information Update: 19 Nov 1999

Price : $50

At a glance

  • Originator Nonindustrial source; Phytopharm
  • Developer IXICO
  • Class
  • Mechanism of Action Interleukin 4 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Suspended Atopic dermatitis

Most Recent Events

  • 19 Nov 1999 P 1 is available for licensing (http://www.phytopharm.co.uk)
  • 19 Nov 1999 Suspended-Preclinical for Atopic dermatitis in USA (PO)
  • 19 Nov 1999 Suspended-III for Atopic dermatitis in United Kingdom (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top